심부전 1 : Living with Heart Failure |
Apr.21(Fri) 08:50-10:10 Rm.103 |
Chairpersons |
오병희, 전은석 |
Panel |
김명아, 유승기, 정진옥, 황석재 |
08:50-09:10 |
Management of Stage B Heart Failure |
유병수/연세원주의대 |
09:10-09:30 |
How to Tackle Congestion? |
Wilfried Mullens/ Hasselt Univ., Belgium |
09:30-09:50 |
Periop Consultation for Heart Failure |
김민석/울산의대 |
09:50-10:10 |
How to Manage Stable Heart Failure with Recovered or Improved Ejection Fraction |
조재영/전남의대 |
10:10-10:20 |
Discussion |
[English Session] Suh,Soon-Kyu Memorial Lecture |
Apr.21(Fri) 10:20-11:10 Rm.300C |
Chairperson |
Tai Ho Rho |
Panel |
Young Hak Kim, Duk Woo Park, Seung Woo Park, Jinho Shin |
10:20-10:50 |
Reaching New Heights Through Digital Medicine Research |
Evan Muse/Scripps Green Hospital, USA |
10:50-11:10 |
Discussion |
심부전 2 : Management of End Stage Heart Failure (ESHF) |
Apr.21(Fri) 11:20-12:50 Rm.103 |
Chairpersons |
유규형, 백상홍 |
Panel |
강석민, 정성호, 최진오, 홍석근 |
11:20-11:40 |
Monitoring and Management of Cardiogenic Shock in Patients with End Stage Heart Failure |
위진/연세의대 |
11:40-12:00 |
Mechanical Circulatory Support as BTT; ECMO Versus LVAD |
조양현/성균관의대 |
12:00-12:20 |
Transplantation; Who Should Get the Heart First? |
이해영/서울의대 |
12:20-12:40 |
What Is Best Care for Patients with End Stage Heart Failure? |
박진주/서울의대 |
12:40-12:50 |
Discussion |
산학 1 - SAMJIN |
Apr.21(Fri) 13:00-13:40 Rm.103 |
Antiplatelet Therapy for Coronary Artery Disease and Atrial Fibrillation |
Chairpersons |
안태훈, 윤정한 |
13:00-13:20 |
Current Status of Anti-Platelet Use in Acute Myocardial Infarction: Experiences from the Korea Acute Myocardial Infarction Registry |
김주한/전남의대 |
13:20-13:40 |
Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF Trial |
박상민/한림의대 |
산학 2 - GREEN CROSS & DAEWOONG |
Apr.21(Fri) 13:00-13:40 Rm.105 |
HOPE-3 Trial : Cardiovascular Protective Effects of Candesartan |
Chairpersons |
강덕현, 안영근 |
13:00-13:20 |
The Earlier Control The Better Cardiovascular Outcome: HOPE-3 Trial |
나진오/고려의대 |
13:20-13:40 |
Are ARBs the Same? ARB Review Focusing on Heart Failure& Stroke |
조인정/연세의대 |
산학 3 - BMS |
Apr.21(Fri) 13:00-13:40 Rm.300B |
Oral Anticoagulation, Thrombosis and Bleeding - Improving Patient Care with NOACs |
Chairpersons |
김영대, 김영훈 |
13:00-13:20 |
What Matters to NVAF Patients for Stroke Prevention? : Lessons from ARISTOTLE and RWD |
김형관/서울의대 |
13:20-13:40 |
Personalized Treatment Strategies for Stroke Prevention in AF : Questions and Answers |
김남호/원광의대 |
산학 4 - BOEHRINGER INGELHEIM |
Apr.21(Fri) 13:00-13:40 Rm.300C |
The Future Is Now: Impact of Oral Anticoagulation & Reversal on Your Practice |
Chairpersons |
김효수, 신동구 |
13:00-13:20 |
Where Do We Stand with NOACs in AF? |
박희남/연세의대 |
13:20-13:40 |
New Options for Anticoagulation Reversal: A Practical Approach |
박형욱/전남의대 |
Diamond - BMS |
Apr.21(Fri) 13:40-14:20 Rm.300B |
Controversies in Anticoagulation for Atrial Fibrillation : Barriers or Gateways |
Chairpersons |
김영대, 김영훈 |
13:40-14:00 |
Patient Persistence on Anticoagulation Treatments : Is There Any Difference in NOACs? |
한성욱/계명의대 |
14:00-14:20 |
Optimizing Outcome in NOACs for Gastrointestinal Bleeding Risk |
정보영/연세의대 |
심부전 3 : Case Discussions : Complicated HF Cases, What Should Be Done? |
Apr.21(Fri) 14:40-16:10 Rm.103 |
Chairpersons |
채성철, 조명찬 |
Panel |
김응주, 박대균, 신미승, 양동헌 |
14:40-14:55 |
Similar Morphology, Different Treatment Option |
이주희/충북의대 |
14:55-15:10 |
Acute Cardiogenic Shock with Standing-Still Heart |
이가연/성균관의대 |
15:10-15:25 |
The Phantom Menace |
오재원/연세의대 |
15:25-15:40 |
A Case of Heart Failure with Normal Ejection Fraction |
장세용/경북의대 |
15:40-15:55 |
39 Year-Old Male Patient Presented with Abdominal Distension |
이수용/부산의대 |
15:55-16:10 |
Discussion |
[English Session] 심장대사증후군 : Cardiometabolic Syndrome Cardiometabolic Syndrome: Optimal Risk Management |
Apr.21(Fri) 16:20-17:50 Rm.103 |
Chairpersons |
Kwang Kon Koh, Sang-Hyun Kim |
Panel |
Seong Hwan Kim, Ki Chul Sung, Il Suk Sohn, Kyung-Im Cho, Sang-Ho Jo |
16:20-16:50 |
Total Risk Management in Coronary and High Risk Patients |
David Wood/ Imperial College London, UK |
16:50-17:10 |
Discussion |
17:10-17:25 |
Optimal Management of Dyslipidemia in Diabetes |
Soo Lim/Seoul National Univ., Korea |
17:25-17:40 |
Perspective on Lipids and Lipid Control in Cardiometabolic Syndrome |
Sang-Hak Lee/Yonsei Univ., Korea |
17:40-17:50 |
Discussion |
[English Session] Smart Healthcare : Application of Mobile Health in Cardiovascular Disease |
Apr.21(Fri) 16:20-17:50 Rm.300B |
Chairpersons |
Seung Woo Park, Young Hak Kim |
Panel |
Ju Han Kim, Jinho Shin, Hae-Young Lee |
16:20-16:50 |
Application of Dr.M, An Integrated Mobile Healthcare Strategy, for Treatment of Cardiovascular Disease |
Yong Jeong/KAIST |
16:50-17:20 |
mHealth Innovation: Empowering Patients and Improving Care |
Evan Muse/Scripps Green Hospital, USA |
17:20-17:40 |
Big Data Research for Hypertension: Korean National Health Insurance Service Cohort Study |
Sung Ha Park/Yonsei Univ., Korea |
17:40-17:50 |
Discussion |
*KAIST : Korea Advanced Institute of Science and Technology |
의료정책 : Building Nationwide AMI Registry with Government |
Apr.22(Sat) 08:50-10:10 Rm.102 |
Chairpersons |
김효수, 김병옥 |
Panel |
김현창, 이건세, 이문형, 한규록 |
08:50-09:10 |
Bottom-up Building Approach and Cooperation with Government-the SwedeHeart Registry |
배장환/충북의대 |
09:10-09:25 |
Cardiovascular Disease Control and Prevention Act and Future Plans |
박의준/보건복지부 |
09:25-09:40 |
The Cardiocerebral Vascular Prevention and Management Law(C-V Management Law) and Patient Registration |
이건세/건국의대 |
09:40-09:55 |
Clinical Experience of The Korea Acute Myocardial Infarction Registry and Future Development of KAMIR |
정명호/전남의대 |
09:55-10:05 |
권역심뇌혈관센터 심근경색증 등록사업의 시작 (KRAMI) |
황진용/경상의대 |
10:05-10:20 |
Discussion |
고혈압 : Optimal Management of Specified Hypertension |
Apr.22(Sat) 08:50-10:10 Rm.103 |
Chairpersons |
박창규, 성기철 |
Panel |
박진선, 이주희, 최성훈 |
08:50-09:10 |
Missed Diagnosis of Masked Hypertension : Need to Treat! |
조경임/고신의대 |
09:10-09:30 |
Optimal Treatment Strategy for Morning Blood Pressure Surge and Nocturnal Hypertension |
최재혁/한림의대 |
09:30-09:50 |
Optimal Management of Blood Pressure Variability for Clinical Practice |
신진호/한양의대 |
09:50-10:10 |
White Coat Hypertension : Observation or Treatment? |
조상호/한림의대 |
10:10-10:20 |
Discussion |
소아 1: Adult Congenital Heart DiseaseComplicated Rhythm Disturbances in ACHD |
Apr.22(Sat) 08:50-10:10 Rm.105 |
Chairpersons |
고재곤, 박승우 |
Panel |
반지은, 송미경, 은영민 |
08:50-09:10 |
Clinical Implications of Premature Ventricular Depolarization in Adult with CHD |
허준/성균관의대 |
09:10-09:30 |
Cardiac Resynchronization Therapy for Corrected TGA with Myocardial Dysfunction |
Jun Yoshimoto/ Shizuoka Children's Hospital, Japan |
09:30-09:50 |
What to Do for a 50 Year Old Woman with Inoperable PA VSD and MAPCA Complaining of Recurrent NSVT? |
반지은/이화의대 |
09:50-10:10 |
What to Do for a 75 Year Old Man of Severe Ebstein Anomaly with Decreased RV Function, Atrial Fibrillation |
송종민/울산의대 |
10:10-10:20 |
Discussion |
부정맥-심부전 Joint Session: Device Therapy in Heart Failure |
Apr.22(Sat) 08:50-10:10 Rm.300B |
Chairpersons |
신동구, 최동주 |
Panel |
강석민, 김용균, 노승영, 정욱진 |
08:50-09:00 |
ICD and CRT - Benefit and Guideline |
이영수/대구가톨릭의대 |
09:00-09:10 |
How to Select the Case for ICD and CRT? |
윤종찬/한림의대 |
09:10-09:20 |
When Is Best Time to Refer Patient for CRT |
이상언/울산의대 |
09:20-09:30 |
Monitoring of HF Patients with Devices |
김경희/세종병원 |
09:30-09:40 |
How to Prevent Inappropriate Shock? |
박형섭/계명의대 |
09:40-09:50 |
ICD and CRT are More Effective in Asian HF Patients? |
엄재선/연세의대 |
09:50-10:10 |
Discussion |
[English Session] Plenary Session |
Apr.22(Sat) 10:20-11:10 Rm.300C |
Chairperson |
Seung-Jung Park |
10:20-10:50 |
The Role of Rivaroxaban in Patients with Atrial Fibrillation Undergoing PCI |
Freek W. A. Verheugt/ Onze Lieve Vrouwe Gasthuis, the Netherlands |
10:50-11:10 |
Discussion |
영상 : Recent Updates in Anatomical and Functional Plaque Imaging |
Apr.22(Sat) 11:20-12:50 Rm.102 |
Chairpersons |
범희승, 최연현 |
Panel |
강준원, 조구영, 조인호 |
11:20-11:40 |
Anatomical Plaue Imaging with CT Angiography |
전은주/서울의대 |
11:40-12:00 |
OCT for Plaque Imaging |
김중선/연세의대 |
12:00-12:20 |
Nuclear Imaging Approach to Plaque Characterization |
최준영/성균관의대 |
12:20-12:40 |
Coronary Artery Plaque Imaging in MRI |
김정아/인제의대 |
12:40-12:50 |
Discussion |
흉부외과 : Mechanical Circulartory Support for End Stage Heart failure |
Apr.22(Sat) 11:20-12:50 Rm.103 |
Chairpersons |
정철현, 성기익 |
11:20-11:30 |
Concepts in Circulatory Support and Application of ECMO for End Stage Heart Failure |
위진/연세의대 |
11:30-11:40 |
Predicting Outcomes in VA ECMO Patients |
최진오/성균관의대 |
11:40-11:55 |
How to Manage Major Complications of ECMO |
정인석/전남의대 |
11:55-12:10 |
Current State-of-Art in VAD Therapy for Heart Failure |
정성호/울산의대 |
12:10-12:25 |
LVAD or Heart Transplantation: Determination of Destination Therapy |
윤영남/연세의대 |
12:25-12:40 |
Pitfalls of VAD Implantation and Management of Complications for VAD Patients |
조양현/성균관의대 |
12:40-12:50 |
Discussion |
소아 2: Pediatric & Congenital Cardiac Surgery Perioperative Issues |
Apr.22(Sat) 11:20-12:50 Rm.105 |
Chairpersons |
김성호, 이정렬 |
Panel |
유재현, 이철, 조준용 |
11:20-11:40 |
Myocardial Insult during Cyanotic Congenital Heart Disease Surgery |
이창하/세종병원 |
11:40-12:00 |
What to Do for a Fetus of 24 Weeks of GP with Severe Absent PV Syndrome |
윤태진/울산의대 |
12:00-12:20 |
Low Cardiac Output Syndrome of Postoperative Adult Congenital Heart Disease in ICU |
임홍국/서울의대 |
12:20-12:40 |
Practical Issues of Surgical Ablation for the Redo Adult CHD |
박한기/연세의대 |
12:40-12:50 |
Discussion |
산학 5 - DAIICHISANKYO & DAEWOONG |
Apr.22(Sat) 13:00-13:40 Rm.102 |
Adherence for Cardiovascular Disease Patients, “1pill" |
Chairpersons |
김준수, 조명찬 |
13:00-13:20 |
Scientific Evidence and Real Practice on Stroke Prevention of AF patients with Anticoagulation |
최의근/서울의대 |
13:20-13:40 |
Challenges in Hypertension 2017 |
손일석/경희의대 |
산학 6 - PFIZER |
Apr.22(Sat) 13:00-13:40 Rm.103 |
Improving CV Outcomes in High CV Risk Patients |
Chairpersons |
김영대, 김동운 |
13:00-13:20 |
Applying 2013 ACC/AHA Guideline into Korean Patients |
장기육/가톨릭의대 |
13:20-13:40 |
Weighing the Benefit of Statin Treatment: LDL and Beyond |
박덕우/울산의대 |
산학 7 - BORYUNG |
Apr.22(Sat) 13:00-13:40 Rm.105 |
Update Issues of Hypertension Management |
Chairpersons |
김철호, 전은석 |
13:00-13:20 |
The Effect of Fimasartan BPV |
주승재/제주의대 |
13:20-13:40 |
The New SPC of Fimasartan and Amlodipine |
이종영/성균관의대 |
산학 8 - BAYER |
Apr.22(Sat) 13:00-13:40 Rm.300B |
Start Rivaroxaban with Confidence |
Chairpersons |
정명호, 이문형 |
13:00-13:30 |
Patient-Centric Approaches in Stroke Prevention in Atrial Fibrillation |
Freek W. A. Verheugt/ Onze Lieve Vrouwe Gasthuis, the Netherlands |
13:30-13:40 |
Discussion |
산학 9 - MSD |
Apr.22(Sat) 13:00-13:40 Rm.300C |
The Latest Updates on the Management of Patients with CVD |
Chairpersons |
장양수, 김동수 |
13:00-13:15 |
Indispensable Role of Ezetimibe/Atorvastatin Combination Therapy in ACS/CHD Patients |
김병극/연세의대 |
13:15-13:30 |
The Role of DPP-4 Inhibitors in Patients with CV Risk |
임수/서울의대 |
13:30-13:40 |
Discussion |
Diamond - BAYER |
Apr.22(Sat) 13:40-14:20 Rm.102 |
PIONEER AF-PCI Meet -The-Trialist |
Chairperson |
최동훈 |
Panel |
박덕우, 임홍석, 한주용 |
13:40-14:00 |
PIONEER AF-PCI: Changing Antithrombotic Treatment in Patients with AF Undergoing PCI |
Freek W. A. Verheugt/ Onze Lieve Vrouwe Gasthuis, Netherlands |
14:00-14:15 |
Antithrombotic Strategy of Rivaroxaban for AF Patients Undergoing PCI in Real Practice |
김병극/연세의대 |
14:15-14:30 |
Discussion |
여성심질환 : Common Comorbidities and Cardiovascular Disease |
Apr.22(Sat) 14:40-16:10 Rm.102 |
Chairpersons |
심완주, 정명호 |
Panel |
강석민, 홍경순, 황규리 |
14:40-15:00 |
Is Osteoporosis Linked with Cardiovascular Disease? |
김광일/서울의대 |
15:00-15:20 |
Is Hypothyroidism A Risk Factor for Cardiovascular Disease? |
김신곤/고려의대 |
15:20-15:40 |
Is It Time to Reconsider Hormon Replacement Therapy? |
한기훈/울산의대 |
15:40-16:00 |
Discussion |
기초 1 : Atherosclerosis |
Apr.22(Sat) 14:40-16:10 Rm.103 |
Chairpersons |
정익모, 안영근 |
Panel |
민필기, 이상학, 임병관 |
14:40-15:00 |
Role of Mechanosensor in Endothelial Cells |
권기환/이화의대 |
15:00-15:20 |
Role of TLR2 in the Pathogenesis of Atherosclerosis |
박성하/연세의대 |
15:20-15:40 |
Control of Autoimmune T Cell Responses by Hypercholesterolemia |
정연석/서울대 |
15:40-16:00 |
Endothelial Progenitor Cell in Coronary Artery Disease |
김원/경희의대 |
16:00-16:10 |
Discussion |
소아 3: Pediatric Cardiology 1Back to Basic in Congenital Heart Disease |
Apr.22(Sat) 14:40-16:10 Rm.105 |
Chairpersons |
김남수, 주찬웅 |
Panel |
오진희, 유경희, 이정하, 장소익 |
14:40-15:00 |
Measurement of Intra & Extracardiac Shunt ; Echo/Cath/MRI |
이재영/가톨릭의대 |
15:00-15:20 |
How Cyanotic Is Too Critical? |
이형두/부산의대 |
15:20-15:40 |
When Is Risky to Apply Oxygen for Congenital Heart Disease? |
최은영/세종병원 |
15:40-16:00 |
Volume Replacement in Patient with Congenital Heart Disease; Caution! |
천은정/건양의대 |
16:00-16:10 |
Discussion |
심근경색 1 : Issue and Debate in the Management of Acute Myocardial Infarction |
Apr.22(Sat) 14:40-16:10 Rm.300C |
Chairpersons |
김종진, 김효수 |
Panel |
나득영, 남창욱, 이중희 |
14:40-15:00 |
Potent Platelet Inhibition in Korean AMI Patients |
박용휘/경상의대 |
15:00-15:20 |
Optimal Timing of Invasive Strategy in NSTEMI Patient: Immediate or Delayed? |
이상엽/충북의대 |
15:20-15:40 |
PCI Under Hemodynamic Support for High Risk AMI Patients: for Whom, When, and with What? |
노재형/경북의대 |
15:40-16:00 |
Adjunctive Therapy to Reduce Infarct Size: Current and Future Challenges |
윤창환/서울의대 |
16:00-16:10 |
Discussion |
혈관 : Current Advance of Management in Vascular Disease |
Apr.22(Sat) 16:20-17:50 Rm.102 |
Chairpersons |
이무용, 편욱범 |
Panel |
김수아, 신정훈, 이종영 |
16:20-16:40 |
Anti-Inflammatory Strategies for Preventing Cardiovascular Events |
김응주/고려의대 |
16:40-17:00 |
Ambulatory Arterial Stiffness Monitoring, As Good As Ambulatory Blood Pressure Monitoring? |
이해영/서울의대 |
17:00-17:20 |
Carotid Plaque and Stenosis: What Is the Best Management? |
안철민/연세의대 |
17:20-17:40 |
Vein and Lymphatics in Edema Patients |
황지혜/성균관의대 |
17:40-17:50 |
Discussion |
[English Session] 기초 2 : Myocardial Fibrosis |
Apr.22(Sat) 16:20-17:50 Rm.103 |
Chairpersons |
Sang Hong Baek, Donghoon Choi |
Panel |
Jae-Hyeong Park, Hyun-Young Park, Sung Woo Cho |
16:20-16:50 |
Aging Signaling Promotes Pathologies in Heart Failure |
Ippei Shimizu/ Niigata University, Japan |
16:50-17:05 |
Ca2+ Signaling: Positive Regulation of Nox2 by TRPC3 Channel Mediates Mechanical Stress-Induced Cardiac Fibrosis |
Takuro Numaga-Tomita/ National Institute for Physiological Sciences, Japan |
17:05-17:20 |
Histone Deacetylase Inhibition in Cardiovascular Diseases |
Hae Jin Kee/Chonnam National Univ., Korea |
17:20-17:35 |
Mitochondrial Dysfunction |
Jin Han/Inje Univ., Korea |
17:35-17:50 |
Discussion |
소아 4: Pediatric Cardiology 2Back to Basic 2 : Rhythm Devices in Pediatric and Congenital Heart Disease |
Apr.22(Sat) 16:20-17:50 Rm.105 |
Chairpersons |
노정일, 성시찬 |
Panel |
반지은, 이영석, 최창휴 |
16:20-16:40 |
Single Chamber Ppm vs Dual Chamber Ppm in Children |
조민정/부산의대 |
16:40-17:00 |
Epicardial vs Endocardial Pacing System |
이상윤/세종병원 |
17:00-17:20 |
Trouble Shooting of Pacemaker in Children |
Jun Yoshimoto/ Shizuoka Children's Hospital, Japan |
17:20-17:40 |
Complications Related to Implanted Pacemaker |
양지혁/성균관의대 |
17:40-17:50 |
Discussion |
심근경색 2 : Various Aspects about Myocardial Infarction Management |
Apr.22(Sat) 16:20-17:50 Rm.300C |
Chairpersons |
채성철, 정명호 |
Panel |
김현국, 조진만, 황진용 |
16:20-16:40 |
Managements of Atrial Fibrillation in Myocardial Infarction |
배명환/경북의대 |
16:40-17:00 |
Myocardial Perfusion Imaging in Multivessel Disease |
조상건/전남의대 |
17:00-17:20 |
Surgeon's View to Treat Myocardial Infarction |
윤영남/연세의대 |
17:20-17:40 |
Current Status of Cardiac Rehabilitation in Korean Post-MI Patients |
김원석/서울의대 |
17:40-17:50 |
Discussion |
KHRS 1 |
Apr.21(Fri) 08:50-10:10 Rm.300B |
ECG Interpretation: A Case-Based Review |
Chairpersons |
조정관, 이만영 |
Panel |
곽재진, 문희선, 배명환, 임성일, 현대우 |
08:50-09:05 |
ECG Basics |
박종성/동아의대 |
09:05-09:20 |
Sinus Node Dysfunction |
반지은/이화의대 |
09:20-09:35 |
AV Node and AV Block |
신대희/가톨릭관동의대 |
09:35-09:50 |
Narrow QRS Tachycardia |
이정명/경희의대 |
09:50-10:05 |
Wide QRS Tachycardia |
고점석/원광의대 |
10:05-10:20 |
Discussion |
KHRS 2 |
Apr.21(Fri) 11:20-12:50 Rm.300B |
Stroke Summit: Stroke Prevention and Anticogulation |
Chairpersons |
김준수, 최기준 |
Panel |
김동민, 안민수, 안진희, 이혜영 |
11:20-11:30 |
Risk Stratification of Thromboembolism and Hemorrhage |
김태훈/연세의대 |
11:30-11:40 |
Cryptogenic Stroke and Undelying Atrial Fibrillation |
차명진/서울의대 |
11:40-11:50 |
Characteristics of NOAC |
김남호/원광대학교 의과대학병원 |
11:50-12:00 |
Special Conditions of NOAC: PCI, Etc |
장성원/가톨릭의대 성바오로병원 |
12:00-12:10 |
Hemorrhage Management and Antidote of NOAC |
박준범/이화여자대학교 목동병원 |
12:10-12:30 |
Asian Strategy for Stroke Prevention in Atrial Fibrillation |
Tze-Fan Chao/ Taipei Veterans General Hospital, Taiwan |
12:30-12:50 |
Discussion |
KHRS 3 |
Apr.21(Fri) 14:40-16:10 Rm.300B |
AF Summit: Atrial Fibrillation |
Chairpersons |
오동진, 김영훈 |
Panel |
김주연, 김준형, 박환철, 이기홍 |
14:40-14:50 |
Epidemiology and Mechanism of Atrial Fibrillation |
차태준/고신의대 |
14:50-15:00 |
Rate and Rhythm Control of Atrial Fibrillation |
심재민/고려의대 |
15:00-15:10 |
Outcomes of AF Ablation |
남기병/울산의대 |
15:10-15:20 |
New Techniques for Atrial Fibrillation Ablation |
한성욱/계명의대 |
15:20-15:30 |
More Unmet Challeges in Atrial Fibrillation Ablation |
박희남/연세의대 |
15:30-15:40 |
Anticoagulation During Atrial Fibrillation Ablation |
김진석/고려의대 |
15:40-15:50 |
LAA Occluder |
임홍의/고려의대 |
15:50-16:10 |
Discussion |
KHRS 4 |
Apr.22(Sat) 11:20-12:50 Rm.300B |
Debate : Issues in Arrhythmia |
Chairpersons |
노태호, 오용석 |
Panel |
강기운, 김유리, 박예민, 장진근 |
NOAC is More Effective in Asian AF Patients? |
11:20-11:35 |
Pro |
오세일/서울의대 |
11:35-11:50 |
Con |
정보영/연세의대 |
11:50-12:05 |
Discussion |
Genetic Test in Arrhythmia?; Sudden Death in Patients without Structural Heart Disease |
12:05-12:20 |
Pro |
윤남식/전남의대 |
12:20-12:35 |
Con |
최종일/고려의대 |
12:35-12:50 |
Discussion |
KHRS 5 |
Apr.22(Sat) 14:40-16:10 Rm.300B |
PSVT and Idiopathic VT |
Chairpersons |
김유호, 이문형 |
Panel |
권창희, 박진규, 이대인, 조영진 |
14:40-14:50 |
AVNRT |
김종윤/연세의대 |
14:50-15:00 |
WPW, AVRT |
이명용/단국의대 |
15:00-15:10 |
Complex Supraventricular Tachycardia |
김성환/가톨릭의대 |
15:10-15:20 |
Outflow VT |
온영근/성균관의대 |
15:20-15:30 |
Fasciular VT |
최의근/서울의대 |
15:30-15:40 |
Left Ventricular Summit Ventricular Arrhythmia |
박경민/성균관의대 |
15:40-16:10 |
Discussion |
KHRS 6 |
Apr.22(Sat) 16:20-17:50 Rm.300B |
CIED Summit: CIED and Future |
Chairpersons |
곽충환, 정병천 |
Panel |
김동민, 남궁준, 신승용, 한상진 |
16:20-16:30 |
Solving Complication During CIED Followup |
김준/울산의대 |
16:30-16:40 |
Management of CIED Infection and Lead Extraction |
박상원/세종병원 |
16:40-16:50 |
New technique in CIED: Subcutaenous ICD, Leadless Pacemaker, Etc |
황교승/아주의대 |
16:50-17:00 |
Recall Issues in CIED |
박형욱/전남의대 |
17:00-17:10 |
CIED in Inherited Arrhythmia |
조용근/경북의대 |
17:10-17:20 |
Stem Cell and Gene Therapy of Arrhythmia |
성정훈/차의대 |
17:20-17:50 |
Discussion |
KSIC 1 |
April 21(Fri), 08:50-10:10 Rm300C |
Fusion Tools for PCI: Imaging and Physiology |
Chairpersons |
오동주/고려의대, 탁승제/아주의대 |
Panel |
김상욱, 김수중, 김중선, 남창욱, 윤경호, 이봉기 |
08:50-09:02 |
How to Optimize? Aspect of IVUS Believer |
홍영준/전남의대 |
09:02-09:14 |
How to Optimize? Aspect of OCT Believer |
허정호/고신의대 |
09:14-09:26 |
How to Optimize? Aspect of FFR Believer |
도준형/인제의대 |
[HOT DEBATE SESSION I] |
09:26-09:38 |
[Debate I] I Prefer Angio-Guided PCI |
배장환/충북의대 |
09:38-09:50 |
[Debate II] I Prefer Imaging-Guided PCI |
신은석/울산의대 |
09:50-10:10 |
Discussion |
KSIC 2 |
April 21(Fri), 11:20-12:50 Rm300C |
TAVR: Know-How From Experts in Korea |
Chairpersons |
박승정/울산의대, 윤정한/원주연세의대 |
Panel |
김주한, 김준홍, 김현국, 안정민, 조윤형, 최영진 |
11:20-11:35 |
Updated TAVR data: Current Status and Future Perspective |
김주한/전남의대 |
11:35-11:50 |
How to Minimize TAVR Complications? |
장기육/가톨릭의대 |
11:50-12:05 |
SAPIEN: Tips and Tricks |
박덕우/울산의대 |
12:05-12:20 |
Evolute: Tips and Tricks |
홍명기/연세의대 |
12:20-12:35 |
Lotus: Tips and Tricks |
김효수/서울의대 |
12:35-12:50 |
Discussion |
KSIC 3 |
April 21(Fri), 14:40-16:10 Rm300C |
Updated Left Main Revascularization: Pre- and Post-EXCEL and NOBLE Era |
Chairpersons |
장양수/연세의대, 김영대/동아의대 |
Panel |
김원, 김진원, 이상록, 이준희, 채인호, 홍범기 |
14:40-14:55 |
Similarity or Disparity of EXCEL and NOBLE: How to Interpret and How to Apply in Real-World |
정우영/서울의대 |
14:55-15:10 |
Updated Meta-Analysis of LM Trials |
장재식/인제의대 |
15:10-15:25 |
How to Optimize LM PCI in Contemporary Practice? Lessons from the Expert |
배장호/건양의대 |
[HOT DEBATE SESSION II] |
15:25-15:40 |
[Debate I] PCI is Good: I Like EXCEL |
박승정/울산의대 |
15:40-15:55 |
[Debate II] Surgery is Better: I Like NOBLE |
김기봉/서울의대 |
15:55-16:10 |
Discussion |
KSIC 4 |
April 22(Sat), 08:50-10:10 Rm300C |
For Young Interventionalist: "A-to-Z" Peripheral Intervention from Bottom to Top |
Chairpersons |
안태훈/가천의대, 최동훈/연세의대 |
Panel |
윤창환, 윤혁준, 이종영, 조용락, 조윤형, 진한영 |
08:50-09:02 |
BTK |
이승환/울산의대 |
09:02-09:14 |
SFA |
나승운/고대의대 |
09:14-09:26 |
Iliac |
김수홍/부산보훈병원 |
09:26-09:38 |
Aorta |
이한철/부산의대 |
09:38-09:50 |
Carotid |
이재환/충남의대 |
09:50-10:10 |
Discussion |
KSIC 5 |
April 22(Sat), 11:20-12:50 Rm300C |
BRS: Concerns and Reality |
Chairpersons |
승기배/가톨릭의대, 김효수/서울의대 |
Panel |
김두일, 김범준, 김병극, 박경우, 이상엽, 전국진 |
11:20-11:35 |
Updated BRS Data: Safety Issues and Long-Term Benefit |
홍순준/고려의대 |
11:35-11:50 |
BRS PCI Technique: How to Avoid Suboptimal Results |
한주용/성균관의대 |
11:50-12:05 |
Antithrombotic Therapy in BRS PCI |
오석규/원광의대 |
12:05-12:20 |
BRS Imaging: What We Learned? |
최소연/아주의대 |
12:20-12:35 |
Complications of BRS: Stent Thrombosis and Restenosis |
이상록/전북의대 |
12:35-12:50 |
Discussion |
KSE 1 |
Apr.21(Fri) 08:50-10:20 Rm.102 |
Issues & Updates in Valvular Disease |
Chairpersons |
김순길/한양의대, 주승재/제주의대 |
08:50-09:10 |
Aortic Valve Replacement Surgery Using Sutureless Valve in Severe Aortic Stenosis |
이삭/연세의대 |
09:10-09:30 |
Diagnosis and Management of Degenerative Mitral Regurgitation |
강덕현/울산의대 |
09:30-09:50 |
Echocardiographic Assessment of Prosthetic Valves |
신성희/인하의대 |
09:50-10:10 |
Management of Tricuspid Regurgitation in 2017 |
김계훈/전남의대 |
10:10-10:20 |
Question and Answer |
KSE 2 |
Apr.21(Fri) 11:20-12:50 Rm.102 |
Instructive Cases with Echocardiography |
Chairpersons |
심완주/고려의대, 손대원/서울의대 |
Panel |
송종민/울산의대, 박태호/동아의대, 손일석/경희의대, 박재형/충남의대 |
11:20-11:40 |
Mitral Regurgitation |
조정선/가톨릭의대 |
11:40-12:00 |
Aortic Regurgitation |
양동헌/경북의대 |
12:00-12:20 |
Tricuspid Regurgitation |
심지영/연세의대 |
12:20-12:40 |
Aortic Stenosis |
박성지/성균관의대 |
12:40-12:50 |
Panel Discussion |
KSE 3 |
Apr.21(Fri) 14:40-16:10 Rm.102 |
Issues & Updates in Cardiomyopathy and Heart Failure |
Chairpersons |
송재관/울산의대, 박승우/성균관의대 |
14:40-15:00 |
Differential Diagnosis in the Setting of Increased Left Ventricular Wall Thickness |
김형관/서울의대 |
15:00-15:20 |
Restrictive Cardiomyopathy; Amyloidosis and Others |
홍그루/연세의대 |
15:20-15:40 |
Assessment of Ventricular Diastolic Function in Myocardial & Pericardial Diseases |
김미정/가톨릭의대 |
15:40-16:00 |
Constrictive Pericarditis: A Treatable Diastolic Heart Failure |
장성아/성균관의대 |
16:00-16:10 |
Question and Answer |
KSE 4 |
Apr.21(Fri) 16:20-17:30 Rm.102 |
Instructive Cases with Echocardiography |
Chairpersons |
장경식/조선의대, 정해억/가톨릭의대 |
Panel |
조구영/서울의대, 이상철/성균관의대, 유승기/을지의대, 김형섭/계명의대 |
16:20-16:40 |
Restrictive Cardiomyopathy |
이사민/울산의대 |
16:40-17:00 |
Hypertrophic Cardiomyopathy |
윤현주/전남의대 |
17:00-17:20 |
Heart Failure with Preserved Ejection Fraction |
최성훈/한림의대 |
17:20-17:30 |
Panel Discussion |
Symposium I: Gut Microbiota, Brown Fat and Atherosclerosis |
April 21(Fri), 08:50~10:20 Rm.105 |
Chairpersons |
이인규, 김영미 |
Panel |
김인준, 박영미, 이우제, 조경현, 한진, 홍순준 |
08:50~09:05 |
Gut Microbiota, Cardiometabolic Risk and Atherosclerosis |
김윤근/MD 헬스케어 |
09:05~09:20 |
Gut Symbionts Enhance the Innate Immunity |
이복률/부산대 약대 |
09:20~09:35 |
Gut Microbiota on the Metabolic Diseases |
권미나/울산대 |
09:35~09:50 |
Gut Bile Acid Signaling Controls Fat Browning, Energy Expenditure And Pancreatic Beta Cell Physiology |
황성순/연세대 의생명과학부 |
09:50~10:05 |
Regulation of Systemic Energy Homeostasis by Peripheral Serotonin |
김하일/KAIST |
10:05~10:20 |
Panel Discussion |
Symposium II: Special Debate Session |
April 21(Fri), 10:20~11:10 Rm.105 |
(Intensive) Lipid Lowering Therapy in Elderly Patients |
Chairpersons |
서홍석, 박중열 |
Panel |
김현민, 이상열, 이상학, 임영효, 진상만, 최철웅 |
10:20~10:35 |
Pros |
이종영/성균관의대 |
10:35~10:50 |
Cons |
김광일/서울의대 |
10:50~10:55 |
Rebuttals |
10:55~11:10 |
Panel Discussion |
Symposium III: Special Issue and Controversy in Cardiovascular Nutrition |
April 21(Fri), 11:20~12:50 Rm.105 |
Chairpersons |
신현호, 김양하 |
Panel |
강수진, 김상현, 박형규, 서지아, 이은정, 최성희 |
11:20~11:40 |
Controversy over Very High Fat Diet for Cardiovascular Risks |
김은미/강북삼성병원 |
11:40~12:00 |
Updated Nutraceutical Approaches for the Treatment of Cardiometabolic Risk |
김오연/동아대학교 |
12:00~12:20 |
Estimating Changes in Burdens of Cardiometabolic Health due to Dietary Transition in Korea |
신민정/고려대학교 |
12:20~12:40 |
New ESC/EAS Guideline for Management of Dyslipidemia |
정창희/울산의대 |
12:40~12:50 |
Panel Discussion |
Symposium IV: How to Interpret Recent CV Outcome Trials ? |
April 21(Fri), 14:40~16:20 Rm.105 |
Between the Lines! From Clinical Trials to Real Practice! |
Chairpersons |
이문규, 김효수 |
Panel |
김소헌, 김재현, 박경우, 박훈준, 임수, 정인경 |
14:40~14:55 |
PCSK9 Inhibitors |
서우근/성균관의대 |
14:55~15:10 |
CETP Inhibitors |
김장영/연세원주의대 |
15:10~15:25 |
Statin (including HOPE-3) |
이왕수/중앙의대 |
15:25~15:40 |
GLP1 Agonists (including LEADER, SUSTAIN 6) |
배지철/성균관의대 |
15:40~15:55 |
SGLT2 Inhibitors (including EMPA-REG OUTCOME) |
윤지성/영남의대 |
15:55~16:20 |
Panel Discussion |
Symposium V: Special Debate Session |
April 21(Fri), 16:20~17:40 Rm.105 |
What Is the Major Trigger of Initiating Statin Treatment? |
Chairpersons |
김치정, 박경수 |
Panel |
김용재, 김재택, 김학령, 김혜진, 문민경, 조현재 |
16:20~16:35 |
Coronary Image with Plaque Burden |
박재형/고려의대 |
16:35~16:50 |
Carotid and Cerabrovascular Image with Plaque Burden |
박종호/명지병원 |
16:50~17:05 |
Laboratory Result (LDL-Cholesterol and Particles) |
구보경/서울의대 |
17:05~17:20 |
CV Risk-Based |
김대중/아주의대 |
17:20~17:40 |
Panel Discussion |